Novel RNA therapeutic targeting  sodium channelopathies front page preview

Novel RNA therapeutic targeting sodium channelopathies

Genetic epilepsies caused by mutations to voltage-gated sodium channels do not currently have adequate treatment options. These diseases begin in the early years of life, with infants suffering severe seizures as well ...

pdf 313.4KB

Modulating macrophage plasticity for the treatment of disease front page preview

Modulating macrophage plasticity for the treatment of disease

Researchers in RCSI have discovered that enhancing the expression of a particular enzyme maintains macrophages in an anti-inflammatory and tissue regenerative state. They have developed a target site blocker which up-reg...

pdf 305.4KB

A Novel Target For Obesity And Metabolic Syndrome front page preview

A Novel Target For Obesity And Metabolic Syndrome

RCSI researchers have discovered a novel target, FKBPL, which regulates energy expenditure, and have shown that obesity and Type 2 diabetes (T2D) develop when levels of this protein are low in mice and humans. Proof of...

pdf 291.7KB

Augmented Reality Toolkit front page preview

Augmented Reality Toolkit

The AR Toolkit is a cross-platform augmented reality template for Unity developers to easily create custom augmented reality applications with full support for iOS and Android. App developers can use the AR Toolkit to bu...

pdf 644.3KB

Novel Epigenetic Biomarkers and Targets for Metastatic Colorectal Cancer front page preview

Novel Epigenetic Biomarkers and Targets for Metastatic Colorectal Cancer

Researchers at RCSI have developed a novel biomarker panel to identify patients with colorectal cancer who are at high risk of developing metastatic disease. The team are seeking industry partners to co-develop this pred...

pdf 497.7KB